上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1287Please respect copyright.PENANAMFBSrUjJuG
1287Please respect copyright.PENANAMV2z8I8T6S
上集:https://www.penana.com/article/4711251287Please respect copyright.PENANA8qQ91SUSRQ
1287Please respect copyright.PENANAUIaveIuehU1287Please respect copyright.PENANAPpSJhnN4kx
1287Please respect copyright.PENANAnYKmVRAgK3
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1287Please respect copyright.PENANAjGI1JgSOlB
1287Please respect copyright.PENANAmEURGslQ3n
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1287Please respect copyright.PENANAde8pSsePNC
1287Please respect copyright.PENANA0wq6PtD5hE
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1287Please respect copyright.PENANAeKAoSzslaz
1287Please respect copyright.PENANAUauog8TbBJ1287Please respect copyright.PENANAB5XQOpB3U6
1287Please respect copyright.PENANAGh3ZPHZZQN
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1287Please respect copyright.PENANAq6x7flNKd8
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1287Please respect copyright.PENANATfmd3RxjDE
1287Please respect copyright.PENANAnLms78iJOm
忘記甚麼是Neoantigen的話,可重溫上一集。1287Please respect copyright.PENANAzLd7Ek0UiH
1287Please respect copyright.PENANAQvk9pK2AcS
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1287Please respect copyright.PENANA3O7zWUFOTK
1287Please respect copyright.PENANAVWUsOas2U2
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1287Please respect copyright.PENANAJlFBOW6y6S
1287Please respect copyright.PENANAzJCdcqMDHa1287Please respect copyright.PENANAWE2FjoZukC
1287Please respect copyright.PENANAhm83jd6yl1
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1287Please respect copyright.PENANAfYB8D68UY2
1287Please respect copyright.PENANA7TsjVXqgCH
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1287Please respect copyright.PENANAttBj3eH4Ca
1287Please respect copyright.PENANAJq5hhP8aNe
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1287Please respect copyright.PENANA7PUO3mKaOX1287Please respect copyright.PENANAq7DlS8SA9A
1287Please respect copyright.PENANAm5NgYj7qHL
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1287Please respect copyright.PENANAYDVrckP113
1287Please respect copyright.PENANAixo2syCjgj
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1287Please respect copyright.PENANAWXPyHvV3Gp1287Please respect copyright.PENANAvMNQni88O9
1287Please respect copyright.PENANA1uGl46cPfq
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1287Please respect copyright.PENANAXNnJLaNs4h
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1287Please respect copyright.PENANA59EaRUOiF2
1287Please respect copyright.PENANAgPk33HE5H0
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1287Please respect copyright.PENANAQoiriWuRk0
1287Please respect copyright.PENANA7vhZIdShQX
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1287Please respect copyright.PENANADXLSufSsQE
1287Please respect copyright.PENANARs6jl73CkD
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1287Please respect copyright.PENANAscknKLAGaO
1287Please respect copyright.PENANAsxjuNfDaaI
1287Please respect copyright.PENANA2rt9yn997m
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1287Please respect copyright.PENANAnc5WR8xC4w
1287Please respect copyright.PENANATW8xSCiMFV
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1287Please respect copyright.PENANA4xwWiccOwB
1287Please respect copyright.PENANAFd9YEK1Ios
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1287Please respect copyright.PENANAOL8BN9wPjT
1287Please respect copyright.PENANAILjhJFlTIQ
Link:1287Please respect copyright.PENANAVNNW5eqPft
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1287Please respect copyright.PENANAR9CWyXMDHi
1287Please respect copyright.PENANAzZHguSD5YD
1287Please respect copyright.PENANAwrnVQTkST5
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1287Please respect copyright.PENANAWGBnJ1avQn